Localized AL amyloidosis: A suicidal neoplasm?

References

• Jarrett JT, Lansbury PT. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 1993;73:1055–8.
   PubMed Web of Science ®Google Scholar
• Bhagwandeen BS, Taylor S. Primary localized amyloidosis of the bladder with a monoclonal plasma cell infiltrate. Pathology. 1988;20:67–9.
   PubMed Web of Science ®Google Scholar
• Monge M, Chauveau D, Cordonnier C, Noël LH, Presne C, Makdassi R, Localized amyloidosis of the genitourinary tract: report of 5 new cases and review of the literature. Medicine (Baltimore). 2011;90:212–22.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Amyloid fibril protein nomenclature: 2010 recommendations of the nomenclature committee of the International Society of Amyloidosis. Amyloid. 2010;17:101–4.
   PubMed Web of Science ®Google Scholar
• Solomon A, Frangione B, Franklin EC. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V–VI subgroup of human light chains with amyloidosis AL(l). J Clin Invest. 1982;70:453–60.
   PubMed Web of Science ®Google Scholar
• Stevens FJ. Protein structure, stability, and conformational disease: human antibody light chains 1999. Springfield, VA: National Technical Information Service, U.S. Department of Commerce; 1999.
   Google Scholar
• Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med. 1974;290:473–7.
   PubMed Web of Science ®Google Scholar
• Bellotti V, Mangione P, Merlini G. Review: immunoglobulin light chain amyloidosis—the archetype of structural and pathogenic variability. J Struct Biol. 2000;130:280–9.
   PubMed Web of Science ®Google Scholar
• Glenner GG. Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med. 1980;302:1283–92; 1333–43.
   PubMed Web of Science ®Google Scholar
• Tveteraas T, Sletten K, Westermark P. The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein. Biochem J. 1985;232:183–90.
   PubMed Web of Science ®Google Scholar
• Ramstad HM, Sletten K, Husby G. The amino acid sequence and carbohydrate composition of an immunoglobulin kappa light chain amyloid fibril protein (AL) of variable subgroup I. Amyloid. 1995;2:223–8.
   Web of Science ®Google Scholar
• Omtvedt LA, Bailey D, Renouf DV, Davies MJ, Paramonov NA, Haavik S, Glycosylation of immunoglobulin light chains associated with amyloidosis. Amyloid. 2000;7:227–44.
   PubMed Web of Science ®Google Scholar
• Enqvist S, Sletten K, Westermark P. Fibril protein fragmentation pattern in systemic AL-amyloidosis. J Pathol. 2009;219:473–80.
   PubMed Web of Science ®Google Scholar
• Westermark P. Amyloid in the islets of Langerhans: thoughts and some historical aspects. Ups J Med Sci. 2011;116:81–9.
   PubMed Web of Science ®Google Scholar
• Toyoda M, Ebihara Y, Kato H, Kita S. Tracheobronchial AL amyloidosis: histologic, immunohistochemical, ultrastructural, and immunoelectron microscopic observations. Hum Pathol. 1993;24:970–6.
   PubMed Web of Science ®Google Scholar
• Merrimen JL, Alkhudair WK, Gupta R. Localized amyloidosis of the urinary tract: case series of nine patients. Urology. 2006;67:904–9.
   PubMed Web of Science ®Google Scholar
• Krishnan J, Chu W, Elrod JP, Frizzera G. Tumoral presentation of amyloidosis (amyloidomas) in sof tissues. A report of 14 cases. Am J Clin Pathol. 1993;100:135–44.
   PubMed Web of Science ®Google Scholar
• Fernandez BB, Hernandez FJ. Amyloid tumor of the breast. Arch Pathol. 1973;95:102–5.
   PubMedGoogle Scholar
• Charlot M, Seldin DC, O'hara C, Skinner M, Sanchorawala V. Localized amyloidosis of the breast: a case series. Amyloid. 2011;18:72–5.
   PubMed Web of Science ®Google Scholar
• Paccalin M, Hachulla E, Cazalet C, Tricot L, Carreiro M, Rubi M, Localized amyloidosis: a survey of 35 French cases. Amyloid. 2005;12:239–45.
   PubMed Web of Science ®Google Scholar
• Piazza C, Cavaliere S, Foccoli P, Toninelli C, Bolzoni A, Peretti G. Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients. Eur Arch Otorhinolaryngol. 2003;260:349–54.
   PubMed Web of Science ®Google Scholar
• Godbersen GS, Leh JF, Hansmann ML, Rudert H, Linke RP. Organ-limited laryngeal amyloid deposits: clinical, morphological, and immunohistochemical results of five cases. Ann Otol Rhinol Laryngol. 1992;101:770–5.
   PubMed Web of Science ®Google Scholar
• Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med. 1978;64:814–26.
   PubMed Web of Science ®Google Scholar
• Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis. Arch Dermatol. 2003;139:1157–9.
   PubMedGoogle Scholar
• Biewend ML, Menke DM, Calamia KT. The spectrum of localized amyloidosis: a case series of 20 patients and review of the literature. Amyloid. 2006;13:135–42.
   PubMed Web of Science ®Google Scholar
• Cohen M, Lanska D, Roessmann U, Karaman B, Ganz E, Whitehouse P, Amyloidoma of the CNS. I. Clinical and pathologic study. Neurology. 1992;42:2019–23.
   PubMed Web of Science ®Google Scholar
• Page DL, Isersky C, Harada M, Glenner GG. Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med. 1972;159:75–86.
   PubMedGoogle Scholar
• Westermark P, Sletten K, Pitkänen P, Natvig JB, Lindholm CE. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL. Mol Immunol. 1982;19:447–50.
   PubMed Web of Science ®Google Scholar
• Sletten K, Westermark P, Pitkänen P, Natvig JB, Lindholm C-E. Amino acid sequences in amyloid proteins of κIII immunoglobulin light-chain origin. Scand J Immunol. 1983;18:557–60.
   PubMed Web of Science ®Google Scholar
• Berg AM, Troxler RF, Grillone G, Kasznica J, Kane K, Cohen AS, Localized amyloidosis of the larynx: evidence for light chain composition. Ann Otol Rhinol Laryngol. 1993;102:884–9.
   PubMed Web of Science ®Google Scholar
• Eriksson L, Sletten K, Benson L, Westermark P. Tumour-like localized amyloid of the brain is derived from immunoglobulin light chain. Scand J Immunol. 1993;37:623–6.
   PubMed Web of Science ®Google Scholar
• Olsen KE, Sandgren O, Sletten K, Westermark P. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived amyloid proteins, subtype lV respectevely lVI. Clin Exp Immunol. 1996;106:362–6.
   PubMed Web of Science ®Google Scholar
• Hamidi Asl K, Liepnieks JJ, Nakamura M, Benson MD. Organ-specific (localized) synthesis of Ig light chain amyloid. J Immunol. 1999;162:5556–60.
   PubMed Web of Science ®Google Scholar
• Olsen KE, Sletten K, Sandgren O, Olsson H, Myrvold K, Westermark P. What is the role of giant cells in localized AL amyloidosis? Amyloid. 1999;6:89–97.
   PubMed Web of Science ®Google Scholar
• Zaky ZS, Liepnieks JJ, Rex DK, Cummings OV, Benson MD. Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis. Amyloid. 2007;14:299–304.
   PubMed Web of Science ®Google Scholar
• Kaplan B, Martin BM, Boykov O, Gal R, Pras M, Shechtman I, Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis. Virchows Arch. 2005;447:756–61.
   PubMed Web of Science ®Google Scholar
• Buxbaum J. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin North Am. 1992;6:323–46.
   PubMed Web of Science ®Google Scholar
• Ohmori T, Tabel R, Arita N, Kondo M, Kozawa T, Chikamori Y, Solitary plasmacytoma of the submandibular lymph node with stromal amyloid deposits. Acta Pathol Jpn. 1983;33:999–1007.
   PubMedGoogle Scholar
• Lucas DR, Knox F, Davies S. Apparent monoclonal origin of lymphocytes and plasma cells infiltrating ocular adnexal amyloid deposits: report of 2 cases. Br J Ophthalmol. 1982;66:600–6.
   PubMed Web of Science ®Google Scholar
• Hagari Y, Mihara M, Hagari S. Nodular localized cutaneous amyloidosis: detection of monoclonality of infiltrating plasma cells by polymerase chain reaction. Br J Dermatol. 1996;135:630–3.
   PubMed Web of Science ®Google Scholar
• Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR. Amyloidomas of the nervous system. A monoclonal B-cell disorder with monotypic amyloid light chain l amyloid production. Cancer. 1997;82:362–74.
   Web of Science ®Google Scholar
• Miyamoto T, Kobayashi T, Makiyama M, Kitada S, Fujishima M, Hagari Y, Monoclonality of infiltrating plasma cells in primary pulmonary nodular amyloidosis: detection with polymerase chain reaction. J Clin Pathol. 1999;52:464–70.
   PubMed Web of Science ®Google Scholar
• Setoguchi M, Hoshii Y, Kawano H, Ishihara T. Analysis of plasma cell clonality in localized AL amyloidosis. Amyloid. 2000;7:41–5.
   PubMed Web of Science ®Google Scholar
• Ross P, Magro CM. Clonal light chain restricted primary intrapulmonary nodular amyloidosis. Ann Thorac Surg. 2005;80:344–7.
   PubMed Web of Science ®Google Scholar
• Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, Sjögren's syndrome and localized nodular cutaneous amyloidosis. Arthritis Rheum. 2008;58:1992–9.
   PubMedGoogle Scholar
• Dyke PC, Demaray MJ, Delavan JW, Rasmussen RA. Pulmonary amyloidoma. Am J Clin Pathol. 1974;61:301–5.
   PubMed Web of Science ®Google Scholar
• Barnes EL, Zafar T. Laryngeal amyloidosis. Clinicopathologic study of seven cases. Ann Otol Rhinol Laryngol. 1977;86:856–63.
   PubMed Web of Science ®Google Scholar
• Michaels L, Hyams VJ. Amyloid in localized deposits and plasmacytomas of the respiratory tract. J Pathol. 1979;128:29–38.
   PubMed Web of Science ®Google Scholar
• Schoen FJ, Alexander RW, Hood I, Dunn LJ. Nodular pulmonary amyloidosis. Arch Pathol Lab Med. 1980;104:66–9.
   PubMed Web of Science ®Google Scholar
• Willén R, Willén H, Lindstedt E, Ekelund L. Localized primary amyloidosis of the ureter. Scand J Urol Nephrol. 1983;17:385–9.
   PubMed Web of Science ®Google Scholar
• Da Costa P, Corrin B. Amyloidosis localized to the lower respiratory tract: probably immunoamyloid nature of the tracheobronchial and nodular pulmonary forms. Histopathology. 1985;9:703–10.
   PubMed Web of Science ®Google Scholar
• Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest. 1986;90:827–31.
   PubMed Web of Science ®Google Scholar
• Grünewald K, Sepp N, Weyrer K, Lhotta K, Feichtinger H, Konwalinka G, Gene rearrangement studies in the diagnosis of primary systemic and nodular primary localized cutaneous amyloidosis. J Invest Dermatol. 1991;97:693–6.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Damron TA, Valente AL. Recurrent amyloidoma of soft tissue with exuberant giant cell reaction. Arch Pathol Lab Med. 2003;127:1609–11.
   PubMed Web of Science ®Google Scholar
• Makheshwari AV, Muro-Cacho CA, Kransdorf MJ, Temple HT. Soft-tissue amyloidoma of the extremities: a case report and review of literature. Skeletal Radiol. 2009;38:287–92.
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Pathol. 1975;81:101–16.
   PubMed Web of Science ®Google Scholar
• Helming L, Gordon S. The molecular basis of macrophage fusion. Immunobiology. 2008;212:785–93.
   Web of Science ®Google Scholar
• Enelow RI, Sullivan GW, Carper HT, Mandell GL. Induction of multinucleated giant cell formation from in vitro culture of human monocytes with interleukin-3 and interferon-gamma: comparison with other stimulating factors. Am J Respir Cell Mol Biol. 1992;6:57–62.
   PubMed Web of Science ®Google Scholar
• Fais S, Burgio VL, Silvestri M, Capobianchi MR, Pacchiarotti A, Pallone F. Multinuclear giant cell generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophage fusion and multinucleated giant cell formation. Lab Invest. 1994;71:737–44.
   PubMed Web of Science ®Google Scholar
• McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol. 1995;147:1487–99.
   PubMed Web of Science ®Google Scholar
• Dugast C, Gaudin A, Toujas L. Generation of multinucleated giant cells by culture of monocyte-derived macrophages with IL-4. J Leukoc Biol. 1997;61:517–21.
   PubMed Web of Science ®Google Scholar
• Jenney CR, DeFife KM, Colton E, Anderson JM. Human monocyte/macrophage adhesion, macrophage motility, and IL-4-induced foreign body giant cell formation on silane-modified surfaces in vitro. J Biomed Mater Res. 1998;41:171–84.
   PubMed Web of Science ®Google Scholar
• Helming L, Winter J, Gordon S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J Cell Sci. 2009;122:453–9.
   PubMed Web of Science ®Google Scholar
• McNally AK, Anderson JM. Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells. Exp Mol Pathol. 2011;91:673–81.
   PubMed Web of Science ®Google Scholar
• Ikeda T, Ikeda K, Sasaki K, Kawakami K, Hatake K, Kaji Y, IL-13 as well as IL-4 induces monocytes/macrophages and a monoblastic cell line (UG3) to differentiate into multinucleated giant cells in the presence of M-CSF. Biochem Biophys Res Commun. 1998;253:265–72.
   Google Scholar
• Zhu J, Qiu Y, Valobra M, Qiu S, Majumdar S, Matin D, Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:1125–33.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, MacEwan SR, Meyerson H, Kirk JT, Anderson JM. The foreign body reaction in T-cell-deficient mice. J Biomed Mater Res. 2009;90A:106–13.
   Web of Science ®Google Scholar
• Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C, Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011;21:421–30.
   PubMed Web of Science ®Google Scholar
• Kanoh T, Suzuki K, Kawaguchi S. Multifocal nodular AL amyloidosis in primary Sjögren's syndrome. Rinsho Ketsueki. 1998;39:1157–62; Japanese.
   PubMedGoogle Scholar
• Götz J, Eckert A, Matamales M, Ittner LM, Liu X. Modes of Aβ toxicity in Alzheimer's disease. Cell Mol Life Sci. 2011;68:3359–75.
   PubMed Web of Science ®Google Scholar
• Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid and diabetes mellitus. Physiol Rev. 2011;91:795–826.
   PubMed Web of Science ®Google Scholar
• Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Serum N-terminal and pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation. 2003;107:2440–5.
   PubMed Web of Science ®Google Scholar
• Westermark GT, Sletten K, Westermark P. Alkali-degradation of amyloid: an ancient method useful for making monoclonal antibodies against amyloid fibril proteins. Scand J Immunol. 2009;70:535–40.
   PubMed Web of Science ®Google Scholar